Ketorolac Tromethamine Tablet Suppliers & Bulk Manufacturers

Available Forms: Tablet

Available Strengths: 10 mg

Reference Brands: Ketorol (India), Toradol (USA/EU), Ketril (LATAM)

Category: Analgesic

Ketorolac Tromethamine Injection is utilized by doctors for the short-term treatment of pain, in cases where pain ranges from a moderate to severe degree. It is useful for a treatment administered before or after performing complex medical procedures or surgeries. Ketorolac Tromethamine Tablet is available in Tablet and strengths such as 10 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Ketorolac Tromethamine Tablet is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Ketorolac Tromethamine Tablet can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID) widely used for the short-term management of moderate to severe acute pain. It works by inhibiting the cyclooxygenase (COX) enzymes responsible for the production of prostaglandins, which are substances in the body that cause pain, inflammation, and fever. Due to its strong analgesic and anti-inflammatory properties, ketorolac is often used as an alternative to opioid medications for certain acute pain conditions.

Ketorolac is available in several dosage forms, including oral tablets, nasal spray, intravenous (IV), and intramuscular (IM) injections. It is commonly used in postoperative settings to control pain after surgical procedures. When used as part of a multimodal pain management strategy, ketorolac can be combined with opioid analgesics to enhance pain relief while significantly reducing the required opioid dose.

This opioid-sparing effect helps minimize the risk of opioid-related side effects such as nausea, vomiting, and reduced gastrointestinal motility. Because of its potency and safety considerations, ketorolac is generally recommended for short-term use only, typically not exceeding five days of continuous therapy.